UofL pediatricians selected to serve on prestigious AAP committees


    Two University of Louisville pediatricians have been chosen to serve on prestigious national American Academy of Pediatrics committees.

    Dan L. Stewart, M.D.

    Neonatologist Dan L. Stewart, M.D., has been selected to serve on the American Academy of Pediatrics Committee on the Fetus and Newborn (COFN) which is comprised of nine members. This highly-selective committee studies issues and current advances in fetal and neonatal care; makes recommendations regarding neonatal practice; and collaborates with the American College of Obstetricians and Gynecologists.

    Stewart is assistant director of the Division of Neonatal Medicine and director of nurseries for Kosair Children’s Hospital—the seventh largest NICU in the U.S.—and the University of Louisville Hospital. Stewart is a past president of the Kentucky Chapter of the American Academy of Pediatrics. He serves on the board of the Kentucky Pediatric Society Foundation and is the director of newborn screening programs at several local hospitals. Additionally, Stewart has worked internationally to promote improvements to neonatal care, traveling to countries such as Romania, Moldova, Russia, Poland, Ghana, Ecuador and Vietnam. He has been the primary investigator on numerous National Institutes of Health-funded pharmacology studies as well as studies involving high frequency oscillatory ventilation, surfactant, and inhaled nitric oxide. He has authored 70 peer-reviewed publications and several book chapters.

    Stewart is board certified in pediatrics and neonatal-perinatal medicine, having completed a fellowship in neonatology at the University of Louisville. He attended the University of Louisville for medical school and the Medical College of Virginia and pediatrics residency.

    Janice Sullivan, M.D.

    University of Louisville pediatrician Janice Sullivan, M.D., has been selected to serve on the American Academy of Pediatrics Committee on Drugs. This national committee reviews all aspects of pediatric pharmacology including drug indications, dosing and use precautions. The committee also advises the board of directors in matters related to drug labeling, safety and efficacy for both prescription and over-the-counter drugs; monitors federal legislation related to the drug approval process; and promotes the need for expanded pediatric drug trials.

    Sullivan is the chief and medical director of the Kosair Charities Pediatric Clinical Research Unit. Her research interests center around investigator-initiated studies, Phase I-IV industry-sponsored clinical trials and collaborations with other centers including the NIH funded Pediatric Trials Network (Duke Clinical Research Institute). She has been the principal investigator or sub-investigator on over 200 clinical trials. She also maintains an active critical care practice and has served as a member of the University of Louisville Biomedical Institutional Review Board (HSPPO) since 1998. She is the author of 24 peer-reviewed publications primarily in the areas of pediatric clinical pharmacology and critical care.

    Sullivan is board certified in pediatrics, critical care and clinical pharmacology. She completed fellowships in pediatric pharmacology and critical care at Case Western Reserve University/Rainbow Babies and Children’s Hospital in Cleveland, Ohio.